Model
Edge
Nektar Therapeutics
NKTR
Filing type
S-8
Filing date
Nov 11, 2025
Updated
Nov 12, 2025 ยท 2:17 PM
Copy reference
Filing
S-8
Registration Statement for Securities to be Offered to Employees
Exhibits
EX-4.8
NEKTAR THERAPEUTICS 2025 INDUCEMENT PLAN AND FORMS OF STOCK OPTION AGREEMENT AND RESTRICTED STOCK UNIT AGREEMENT
EX-5.1
OPINION OF GOODWIN PROCTER LLP WITH RESPECT TO THE VALIDITY OF THE SECURITIES
EX-23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic